Contract Option Exercises — August 09, 2026

SIGA's firm-fixed-price contract with HHS/BARDA, valued at $626.5M with $447.2M already outlayed, provides multi-year revenue visibility through 2029, signaling strong government commitment to biodefense.

QTC Medical Services, a Leidos subsidiary, executed a $209.2M VA contract for medical disability exams, with $196.6M outlayed, indicating a completed revenue stream but limited forward visibility.

The non-competed, time-and-materials contract to OUR RESCUE for legal services carries high pricing risk and a short 6-month base period, with potential total value of $244M if options are exercised.

SIGA's $626.5M firm-fixed-price contract exposes the company to cost overruns if development costs exceed estimates, potentially pressuring margins.

The non-competed nature of OUR RESCUE's $158.1M HHS contract could attract protests or lead to a competitive re-solicitation, threatening revenue continuity.

The QTC VA contract and Lockheed Martin NASA award, both defense-related, could face funding delays if a continuing resolution is enacted, impacting execution timelines.

SIGA's long-term BARDA contract positions it for additional biodefense awards, especially as HHS continues to prioritize pandemic preparedness.

The completed $209.2M VA contract signals sustained demand for medical disability exams, with potential for follow-on awards in other regions.

If HHS exercises all options on OUR RESCUE's contract, total value could reach $244M, providing significant revenue for the nonprofit.

The largest contract ($626.5M to SIGA) and a $158.1M legal services award to OUR RESCUE highlight HHS's continued investment in health security and administrative support.

The VA's $209.2M medical exam contract to QTC and NASA's $999,926 R&D award to Lockheed Martin indicate steady, albeit smaller, defense-related spending.

{"entity" => "SIGA Technologies", "reason" => "Large $626.5M BARDA contract with multi-year revenue visibility", "trigger" => "Quarterly earnings for cost performance; any BARDA follow-on solicitations"}

{"entity" => "OUR RESCUE", "reason" => "Sole-source $158.1M HHS contract with high execution risk", "trigger" => "Option exercise decision before February 2027; any protest or re-compete"}

{"entity" => "Leidos Holdings", "reason" => "Completed $209.2M VA contract; potential for follow-on awards", "trigger" => "VA re-compete announcements for medical disability exams"}

{"entity" => "Lockheed Martin", "reason" => "Small NASA R&D contract signals continued engagement", "trigger" => "NASA R&D budget trends; follow-on contract awards"}